Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Larson

Showing results (751-760 of 798) with videos related to

Pageof 80
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Blood|April 14, 2026
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with ImmunochemotherapyProkop Vodička, Tarec C El-Galaly, Vit Prochazka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
European Urology|August 18, 2020
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate CancerDaniel J Schaid, Shannon K McDonnell, Liesel M FitzGerald, et al.
JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.
American Journal of Hematology|January 13, 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R Cerhan, Matthew J Maurer, Brian K Link, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 5, 2011
Assessment of hepatocyte growth factor in ovarian cancer mortalityEllen L Goode, Georgia Chenevix-Trench, Lynn C Hartmann, et al.
The Lancet. Oncology|February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesCeleste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular LymphomaMatthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, et al.
Endocrine-Related Cancer|February 14, 2013
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association ConsortiumCatherine M Olsen, Christina M Nagle, David C Whiteman, et al.
Pageof 80

Showing results (751-760 of 798) with videos related to

Sort By:
Pageof 80
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Blood|April 14, 2026
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with ImmunochemotherapyProkop Vodička, Tarec C El-Galaly, Vit Prochazka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
European Urology|August 18, 2020
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate CancerDaniel J Schaid, Shannon K McDonnell, Liesel M FitzGerald, et al.
JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.
American Journal of Hematology|January 13, 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R Cerhan, Matthew J Maurer, Brian K Link, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 5, 2011
Assessment of hepatocyte growth factor in ovarian cancer mortalityEllen L Goode, Georgia Chenevix-Trench, Lynn C Hartmann, et al.
The Lancet. Oncology|February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesCeleste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular LymphomaMatthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, et al.
Endocrine-Related Cancer|February 14, 2013
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association ConsortiumCatherine M Olsen, Christina M Nagle, David C Whiteman, et al.
Pageof 80